Of these, maspin, ANXA3, LAP3, and PSMA1 were reproducibly discovered as serum-reactive in all 3 initially tested cancer samples, including colon tumor tissue from the 2 patients and the liver metastatic tissue from the patient with primary colon cancer and secondary liver metastasis. This evidence concerns the gene SERPINB5 and malignant colon neoplasm.